Riskpilot← Back to searchSign inGet full accessReBio Technologies Oy
OYActiveY-tunnus 2674946-6Raisionkaari 55Research and experimental development on natural sciences and engineering · NACE 7210Est. 20155 employeeswww.rebiotechnologies.com
Revenue 2025
EUR 0
EBITDA margin
—
+37% vs 2024
Equity ratio
-147.2%
Financial strength
Net profit 2025
EUR -726K
+24% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR -466K | +37% |
| Net profit | EUR -726K | +24% |
| Total assets | EUR 1,6M | -3% |
| Equity | EUR -2,3M | -45% |
| Employees | 5 | — |
Legal name
ReBio Technologies Oy
Y-tunnus number
2674946-6
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. helmikuuta 2015
Share capital
EUR 2 500
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lääkinnällisten valmisteiden ja palveluiden kehittäminen, valmistaminen, markkinointi ja myynti. Yhtiö voi omistaa kiinteistöjä, kiinteistöosakkeita, asunto-osakkeita ja arvopapereita.
Address
Raisionkaari 55
Phone
+3580503639496
Email
harri.jukarainen@rebio.fi
Website
www.rebiotechnologies.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 122 | 29 | 0 |
| Staff expenses | −129 | −132 | −165 | −177 | −194 |
| EBITDA | −271 | −215 | −137 | −736 | −466 |
| Depreciation & amort. | −216 | −151 | −171 | −200 | −239 |
| EBIT | −488 | −366 | −308 | −936 | −706 |
| Net financials | 46 | −44 | −26 | −17 | −21 |
| Profit before tax | −442 | −411 | −334 | −953 | −726 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −442 | −411 | −334 | −953 | −726 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 960 | 1 033 | 1 707 | 1 637 | 1 582 |
| Equity | −895 | −1 306 | −1 440 | −1 603 | −2 329 |
| Long-term debt | 1 771 | 2 175 | 2 638 | 3 113 | 3 486 |
| Short-term debt | 85 | 164 | 508 | 127 | 426 |
| Total debt | 1 855 | 2 339 | 3 147 | 3 240 | 3 911 |
EBITDA margin
-46602400.0%
This company
15.8%
Market median
-294951999% vs market
20212025
Equity ratio
-147.2%
This company
38.2%
Market median
-485% vs market
20212025
Return on equity
-72602100.0%
This company
18.4%
Market median
-394576730% vs market
20212025
Net profit margin
-72602100.0%
This company
8.1%
Market median
-896322322% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.68×
This company
0.62×
Market median
-171% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HJ Chief Executive Officer | Chief Executive Officer | 2016 |
| Former (1) | ||
AI | Audit | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2016 | |
| Chairperson | 2025 | |
| Former (3) | ||
| Board of Directors | 2016 – 2021 | |
| Board of Directors | 2024 – 2025 | |
| Chairperson | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ReBio Technologies Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harri Jari Jukarainen | Chief Executive Officer | 0 companies |
| Antti Iiro Juhani Ikonen | Audit | 0 companies |
| Chang Shao Kang Steven | Board of Directors | 0 companies |
| Patrick Markus Aisher | Board of Directors | 0 companies |
| Robert John Watson | Board of Directors | 0 companies |
| Kristoffer Andenaes | Board of Directors | 0 companies |
| Jonathan Easdon Glen | Chairperson | 0 companies |
| Vinod Vijayakumar | Chairperson | 0 companies |